HOPA Now is the official podcast of the Hematology/Oncology/Pharmacy Association, an organization dedicated to supporting pharmacy practitioners and promoting the advancement of Hematology/Oncology/Pharmacy to optimize the care of individuals impacted by cancer.

 

These educational podcasts are part of our BCOP Preparatory and Recertification Course, which is designed to prepare oncology pharmacists preparing to sit for the BCOP Certification Exam, as well as meet the BPS requirement to complete a BCOP Preparatory/Recertification Review Course.

 

In this episode of HOPA Now, Dr. Allison Duffy highlights the fundamentals of various chronic leukemias, including the background and pathophysiology of CLL, hairy cell leukemia, and CML.  She shares information about the current treatment landscape for this malignancy and highlights the key role that pharmacists can play in treatments as well as drug interaction and administration considerations, supportive care and management, and more.

 

In this episode, you will learn:

 

An overview of chronic leukemia fundamentals

• CLL remains the most prevalent adult leukemia in Western countries.
• CLL and FLL are different manifestations of the same disease which receive similar care.
• Deletion 17p is the single most important prognostic factor in CLL.
• Identifying characteristics and disorders associated with hairy cell leukemia
• CML highlights, including diagnosis, prevention and screening guidelines, and treatment
• The key role of pharmacists in drug interactions and supportive management

 

Mentioned in This Episode:

HOPA

HOPA Now Live Webinars

 

Tweetables:

 

“CLL remains the most prevalent adult leukemia in Western countries.” — Allison Duffy

 

“CML is a unique malignancy in which a single genetic chain acts as the ultimate transformative event.” — Allison Duffy

 

“Collaboration among all pharmacists caring for patients with these malignancies is essential for effective transitions of care and ongoing management across settings.” — Allison Duffy